Author(s): Ott SM
Abstract Share this page
Abstract It is reasonable to stop bisphosphonates after 5 years of use and then to follow patients with markers of bone turnover. As long as the levels of these markers remain reduced, adding an antiresorptive drug does not make physiologic sense.
This article was published in Cleve Clin J Med
and referenced in Journal of Biomedical Engineering and Medical Devices